Abstract:Objective: Estrogen deficiency is associated with unfavorable changes in body composition and metabolic health. While physical activity ameliorates several of the negative effects, loss of ovarian function is associated with decreased physical activity levels. It has been proposed that the changes in brain neurochemical levels and /or impaired skeletal muscle function may underlie this phenomenon. Methods: We studied the effect of estrogen deficiency induced via ovariectomy (OVX) in female Wistar rats (n=64). Rats underwent either sham or OVX surgery and were allocated thereafter into four groups matched for body mass and maximal running capacity: sham/control, sham/max, OVX/control, and OVX/max, of which the max groups had maximal running test before euthanasia to induce acute response to exercise. Metabolism, spontaneous activity, and maximal running capacity were measured before (PRE) and after (POST) the surgeries. Three months following the surgery, rats were euthanized, and blood and tissue samples harvested. Proteins were analyzed from gastrocnemius muscle and retroperitoneal adipose tissue via Western blot. Brain neurochemical markers were measured from nucleus accumbens (NA) and hippocampus (HC) using ultra-high performance liquid chromatography. Results: OVX had lower basal energy expenditure and higher body mass and retroperitoneal adipose tissue mass compared with sham group (p≤0.005). OVX reduced maximal running capacity by 17% (p=0.005) with no changes in muscle mass or phosphorylated form of regulatory light chain (pRLC) in gastrocnemius muscle. OVX was associated with lower serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA) level in the NA compared with sham (p=0.007). In response to acute exercise, OVX was associated with low serotonin level in the HC and high level in the NA (p≤0.024). Conclusions: Our results highlight that OVX reduces maximal running capacity and affects the response of brain neurochemical levels to acute exercise in a brain region-specific manner. These results may offer mechanistic insight into why OVX reduces willingness to exercise.

Estrogen receptors mediate the antidepressant effects of aerobic exercise: A possible new mechanism

Aromatase Changes in Depression: A Postmortem and Animal Experimental Study.

Unveiling the potential of estrogen: Exploring its role in neuropsychiatric disorders and exercise intervention

Estrogen deficiency reduces maximal running capacity and affects serotonin levels differently in the hippocampus and nucleus accumbens in response to acute exercise

Effects of estrogen on behavior and monoamine neurotransmitters of brain tissue in depressed mice

Exercise Ameliorates Anxious Behavior and Promotes Neuroprotection Through Osteocalcin in VCD-induced Menopausal Mice

Estradiol attenuates chronic restraint stress-induced dendrite and dendritic spine loss and cofilin1 activation in ovariectomized mice

17β-Estradiol (E2) alleviates depressive-like behaviors by inhibiting gp130/JAK1/STAT3 signaling pathway through estrogen receptor-β

Neural Mechanisms of Exercise: Anti-Depression, Neurogenesis, and Serotonin Signaling.

Treadmill Exercise Reverses the Change of Dendritic Morphology and Activates BNDF-mTOR Signaling Pathway in the Hippocampus and Cerebral Cortex of Ovariectomized Mice

Effects of E2 on the IDO1-mediated metabolic KYN pathway in OVX female mice

Effects of exercise on depressive-like behavior and ERK/CREB signal pathway in rats under chronic stress

Research on the Neurobiological Mechanisms of the Antidepressant Effects of Physi cal Exercise

Exercise Intervention May Prevent Depression

Exercise alters molecular rhythms in the central nervous system that negatively correlate with depression-like behavior

[Influence of Estradiol on Tryptophan Hydroxylase and 5-Hydroxytryptamine Content in Raphe Nuclei of Rats under Forced Swimming Stress].

Possible role of exercise therapy on depression: Effector neurotransmitters as key players

Estradiol Reduced 5-HT Reuptake by Downregulating the Gene Expression of Plasma Membrane Monoamine Transporter (PMAT, Slc29a4) Through Estrogen Receptor Β and the MAPK/ERK Signaling Pathway.

Metabolic factors-triggered inflammatory response drives antidepressant effects of exercise in CUMS rats